A sophisticated model of the effects of mutating the retinoblastoma gene reveals a window of opportunity in which cells can be released from the normal control of proliferation, before back-up mechanisms take effect.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M. & Jacks, T. Nature 424, 223–228 (2003).
Chau, B. N. & Wang, J. Y. Nature Rev. Cancer 3, 130–138 (2003).
Vooijs, M. & Berns, A. Oncogene 18, 5293–5303 (1999).
Sherr, C. J. Nature Rev. Mol. Cell Biol. 2, 731–737 (2001).
Campisi, J. Trends Cell Biol. 11, S27–S31 (2001).
Schmitt, C. A. et al. Cell 109, 335–346 (2002).
Parrinello, S. et al. Nature Cell Biol. doi:10.1038/ncb1024 (2003).
Dirac, A. M. & Bernards, R. J. Biol. Chem. 278, 11731–11734 (2003).
Dannenberg, J. H., van Rossum, A., Schuijff, L. & te Riele, H. Genes Dev. 14, 3051–3064 (2000).
Rowland, B. D. et al. Cancer Cell 2, 55–65 (2002).
Jaenisch, R. & Bird, A. Nature Genet. 33 (Suppl.), 245–254 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berns, A. Timing will tell. Nature 424, 140–141 (2003). https://doi.org/10.1038/424140a
Issue Date:
DOI: https://doi.org/10.1038/424140a
